Drug-Resistant Focal Epilepsy: When to Refer for Surgery
A 34-year-old man has had focal impaired-awareness seizures since age 12, now occurring 3–4 times per month. He has failed adequate trials of levetiracetam (3000 mg/day), lamotrigine (400 mg/day), and oxcarbazepine (1800 mg/day), each for at least 3 months at tolerated doses, with continued seizures. MRI shows right hippocampal atrophy and increased T2 signal consistent with mesial temporal sclerosis. Video-EEG captured three habitual seizures with right temporal onset. Neuropsychology shows verbal memory scores in the low-average range. He is motivated but worried about memory decline after surgery and asks whether more medication trials are worthwhile.
1. Does he meet criteria for drug-resistant epilepsy, and what is the appropriate next step?
Read the worked answer
Yes - drug-resistant epilepsy is defined as failure of adequate trials of two appropriately chosen and tolerated antiseizure medications (whether monotherapy or in combination) to achieve sustained seizure freedom. He has failed three. The appropriate next step is referral to a comprehensive epilepsy center for presurgical evaluation, not another medication trial. The presence of unilateral mesial temporal sclerosis concordant with ictal EEG onset is a favorable prognostic combination. Continuing to cycle medications delays a potentially curative intervention and exposes him to cumulative side effects.
2. What does the concordance of MRI and EEG findings imply about his surgical candidacy and expected outcome?
Read the worked answer
Unilateral hippocampal sclerosis with concordant ipsilateral temporal ictal onset is the classic favorable profile for anterior temporal lobectomy, with roughly 60–70% seizure freedom at long-term follow-up in such concordant cases. Concordance reduces the need for invasive monitoring in many centers. However, the low-average verbal memory raises the question of whether the sclerotic hippocampus is the language-dominant side; if it is dominant, resection carries a higher risk of verbal memory decline. Wada testing or fMRI language lateralization may be considered. The counseling should present surgery as the intervention with the best chance of seizure freedom, with memory risk discussed honestly.
3. How would you counsel him about memory risk and alternatives if he declines surgery?
Read the worked answer
Explain that verbal memory decline is a real risk, particularly with dominant-side resection, but that ongoing seizures themselves also impair memory and cognition, and seizure freedom often yields net cognitive benefit. Alternatives include further medication trials (lower yield given three failures), dietary therapy (modified Atkins/ketogenic - modest evidence in adults), and neuromodulation: vagus nerve stimulation (palliative, ~50% responder rates) or responsive neurostimulation (for focal seizures with a documented focus, palliative but can reduce seizures). These are not equivalent to resection in seizure-freedom potential. Shared decision-making should include a trial of presurgical discussion with neuropsychology and, if needed, a second opinion. Document the discussion and offer continued follow-up regardless of choice.